Is a complete GPCR research report available?

No complete published report is available for Structure Therapeutics Inc. (GPCR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Structure Therapeutics Inc. (GPCR)

NASDAQ: GPCR · USD

$21.5

-0.10 (-0.5%)· Recorded snapshot

Market cap	1.5B
Net income (ttm)	-214.8M
EPS (ttm)	-$3.22
Shares out	71.3M
Volume	858,804
Beta	-1.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -214.8M
EPS (ttm): -$3.22
Market cap: 1.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001888886
Company name	Structure Therapeutics Inc.
Country	United States
Country code	US
CUSIP number	86366E106
Earnings date	2026-11-09
Earnings time	amc
Employees	281
Employees change	82
Employees growth	41.21%
Enterprise value	$193.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
Industry	Biotechnology
IPO date	2023-02-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US86366E1064
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.5B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$21.45
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GPCR
Tags	pharmaceuticals, weight-loss
U.S. state	California
Website	https://structuretx.com

Metric

Value

Amount currency

USD

CIK code

0001888886

Company name

Structure Therapeutics Inc.

Country

United States

Country code

CUSIP number

86366E106

Earnings date

2026-11-09

Earnings time

amc

Employees

281

Employees change

Employees growth

41.21%

Enterprise value

$193.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2016

Industry

Biotechnology

IPO date

2023-02-03

Is primary listing

Yes

Is SPAC

ISIN number

US86366E1064

Last 10-K release date

2026-02-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.5B

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$21.45

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GPCR

Tags

pharmaceuticals, weight-loss

U.S. state

California

Website

https://structuretx.com

Metric	Value
Earnings yield	-15.01%
FCF / EV yield	-136.95%
FCF yield	-14.96%
Forward EV/Sales	3.28x
Forward P/S	30.01x
P/B ratio	1.13x
Price / tangible book value	1.11x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-15.01%

FCF / EV yield

-136.95%

FCF yield

-14.96%

Forward EV/Sales

3.28x

Forward P/S

30.01x

P/B ratio

1.13x

Price / tangible book value

1.11x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-764,537
ROA	-14.95%
ROA (5Y)	-21.74%
ROCE	-19.72%
ROE	-20.21%
ROE (5Y)	-34.78%
ROIC	-15.65%

Metric

Value

Profit per employee

$-764,537

ROA

-14.95%

ROA (5Y)

-21.74%

ROCE

-19.72%

ROE

-20.21%

ROE (5Y)

-34.78%

ROIC

-15.65%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-4.2M
Depreciation and amortization	$2.3M
EBIT	$-268.1M
EBITDA	$-265.8M
EPS	$-3.22
FCF per share	$-3.15
Financing cash flow	$761.5M
Free cash flow	$-224.5M
Free cash flow minus SBC	$-264.3M
Income taxes	$702,000
Investing cash flow	$-415.6M
Net cash flow	$125.6M
Net income	$-214.8M
Operating cash flow minus SBC	$-260.1M
Operating income	$-268.1M
Stock-based compensation	$39.8M

Metric

Value

Capital expenditures

$-4.2M

Depreciation and amortization

$2.3M

EBIT

$-268.1M

EBITDA

$-265.8M

EPS

$-3.22

FCF per share

$-3.15

Financing cash flow

$761.5M

Free cash flow

$-224.5M

Free cash flow minus SBC

$-264.3M

Income taxes

$702,000

Investing cash flow

$-415.6M

Net cash flow

$125.6M

Net income

$-214.8M

Operating cash flow minus SBC

$-260.1M

Operating income

$-268.1M

Stock-based compensation

$39.8M

Metric	Value
Book value per share	$19.02
Debt / equity	0
Long-term assets	$53.4M
Long-term liabilities	$4.9M
Net cash (debt)	$1.3B
Net cash / market cap	89.07%
Net cash growth	71.6%
Net debt / equity	-0.99
Piotroski F-Score	1
Property, plant and equipment	$12.4M
Shareholders' equity	$1.4B
Tangible book value	$1.4B
Tangible book value per share	$19.02
Total assets	$1.4B
Total cash	$1.3B
Total debt	$6.2M
Total liabilities	$71M
WACC	-3.26%

Metric

Value

Book value per share

$19.02

Debt / equity

Long-term assets

$53.4M

Long-term liabilities

$4.9M

Net cash (debt)

$1.3B

Net cash / market cap

89.07%

Net cash growth

71.6%

Net debt / equity

-0.99

Piotroski F-Score

Property, plant and equipment

$12.4M

Shareholders' equity

$1.4B

Tangible book value

$1.4B

Tangible book value per share

$19.02

Total assets

$1.4B

Total cash

$1.3B

Total debt

$6.2M

Total liabilities

$71M

WACC

-3.26%

Metric	Value
Current assets	$1.4B
Current liabilities	$66.1M
Current ratio	20.75
Net working capital	$-34.1M
Quick ratio	20.31
Working capital	$1.3B

Metric

Value

Current assets

$1.4B

Current liabilities

$66.1M

Current ratio

20.75

Net working capital

$-34.1M

Quick ratio

20.31

Working capital

$1.3B

Metric	Value
Buyback yield / dilution	-16.35%
Dividend yield	0%
Shareholder yield	-16.35%

Metric

Value

Buyback yield / dilution

-16.35%

Dividend yield

Shareholder yield

-16.35%

Metric	Value
150-day SMA	$42.70
1D price change	-0.46%
1M price change	-41.36%
1M total return	-41.36%
1W price change	-7.91%
1W total return	-7.91%
1Y price change	-26.46%
1Y return CAGR	-26.47%
1Y total return	-26.46%
20-day SMA	$23.74
200-day SMA	$49.65
3M price change	-56.73%
3M total return	-56.73%
3Y price change	-69.09%
3Y return CAGR	-32.38%
3Y total return	-69.09%
50-day SMA	$34.65
50-day SMA vs 200-day SMA	50under200
52-week high	$94.90
52-week high date	2025-12-08
52-week low	$20.50
52-week low date	2026-10-28
6M price change	-53.52%
6M total return	-53.52%
All-time high	$94.90
All-time high date	2025-12-08
All-time low	$13.22
All-time low date	2025-04-09
Average true range (ATR)	$1.52
Average volume	1.2M
Beta (1Y)	1.26
Beta (2Y)	1
Beta (5Y)	-1.37
Change from 52-week high	-77.4%
Change from 52-week low	4.63%
Change from all-time high	-77.8%
Change from all-time low	59.38%
Change from open	0.89%
Day's gap	-1.35%
Dollar volume	$18.4M
High price	$21.50
Low price	$20.61
Monthly RSI	42.63
Open price	$21.26
Position in 52-week range	94.38%
Premarket change	0.23%
Premarket close	$21.55
Premarket price	$21.60
Premarket volume	3.3K
Previous close	$21.55
Price vs 150-day SMA	-50.66%
Price vs 20-day SMA	-11.23%
Price vs 200-day SMA	-57.56%
Price vs 50-day SMA	-39.18%
Relative volume	0.69
Return from IPO open	-15.84%
Return from IPO price	40.27%
RSI	22.38
Sharpe ratio	0.13
Sharpe ratio (3Y)	-0.02
Sortino ratio	0.43
Sortino ratio (3Y)	0.04
Volume	858.8K
Weekly RSI	28.56
YTD price change	-69.71%
YTD total return	-69.71%

Metric

Value

150-day SMA

$42.70

1D price change

-0.46%

1M price change

-41.36%

1M total return

-41.36%

1W price change

-7.91%

1W total return

-7.91%

1Y price change

-26.46%

1Y return CAGR

-26.47%

1Y total return

-26.46%

20-day SMA

$23.74

200-day SMA

$49.65

3M price change

-56.73%

3M total return

-56.73%

3Y price change

-69.09%

3Y return CAGR

-32.38%

3Y total return

-69.09%

50-day SMA

$34.65

50-day SMA vs 200-day SMA

50under200

52-week high

$94.90

52-week high date

2025-12-08

52-week low

$20.50

52-week low date

2026-10-28

6M price change

-53.52%

6M total return

-53.52%

All-time high

$94.90

All-time high date

2025-12-08

All-time low

$13.22

All-time low date

2025-04-09

Average true range (ATR)

$1.52

Average volume

1.2M

Beta (1Y)

1.26

Beta (2Y)

Beta (5Y)

-1.37

Change from 52-week high

-77.4%

Change from 52-week low

4.63%

Change from all-time high

-77.8%

Change from all-time low

59.38%

Change from open

0.89%

Day's gap

-1.35%

Dollar volume

$18.4M

High price

$21.50

Low price

$20.61

Monthly RSI

42.63

Open price

$21.26

Position in 52-week range

94.38%

Premarket change

0.23%

Premarket close

$21.55

Premarket price

$21.60

Premarket volume

3.3K

Previous close

$21.55

Price vs 150-day SMA

-50.66%

Price vs 20-day SMA

-11.23%

Price vs 200-day SMA

-57.56%

Price vs 50-day SMA

-39.18%

Relative volume

0.69

Return from IPO open

-15.84%

Return from IPO price

40.27%

RSI

22.38

Sharpe ratio

0.13

Sharpe ratio (3Y)

-0.02

Sortino ratio

0.43

Sortino ratio (3Y)

0.04

Volume

858.8K

Weekly RSI

28.56

YTD price change

-69.71%

YTD total return

-69.71%

Metric	Value
Float	55.5M
Float percentage	77.78%
Shares change (QoQ)	0.29%
Shares change (YoY)	16.35%
Shares held by insiders	2.44%
Shares held by institutions	82.27%
Shares outstanding	71.3M
Short % of shares	14.48%
Short ratio	5.4 days

Metric

Value

Float

55.5M

Float percentage

77.78%

Shares change (QoQ)

0.29%

Shares change (YoY)

16.35%

Shares held by insiders

2.44%

Shares held by institutions

82.27%

Shares outstanding

71.3M

Short % of shares

14.48%

Short ratio

5.4 days

Structure Therapeutics Inc. (GPCR)

Price

Financial snapshot

Fair-value bridge

Latest news · GPCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GPCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GPCR

Frequently asked questions